Keyphrases
Chemotherapy
100%
Everyday Practices
100%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
100%
Tailored Treatment
75%
Histological Subtypes
50%
EGFR mutation
50%
Improved Outcomes
50%
Mutation Status
25%
Literature Search
25%
Retrospective Analysis
25%
Poor Outcome
25%
Non-small Cell Lung Cancer Patients
25%
Non-squamous Non-small Cell Lung Cancer
25%
Quality of Life
25%
Randomized Trial
25%
On-state Current
25%
Progression-free Survival
25%
Pemetrexed
25%
New Biomarkers
25%
Conventional Chemotherapy
25%
Cisplatin
25%
Practice-based
25%
Vinorelbine
25%
Non-small Cell Lung Cancer (NSCLC)
25%
ERCC1
25%
Gefitinib
25%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Chemotherapy
100%
Epidermal Growth Factor Receptor
28%
Biological Marker
28%
Progression Free Survival
14%
Cisplatin
14%
Pemetrexed
14%
Gefitinib
14%
Medicine and Dentistry
Lung Cancer
100%
Biological Marker
28%
Epidermal Growth Factor Receptor
28%
Quality of Life
14%
Progression Free Survival
14%
Upregulation
14%
Cancer Therapy
14%
Vinorelbine
14%
Base Excision Repair
14%
Gefitinib
14%
Cisplatin
14%